EP2970441
Óglýkósýleruð Fc-innihaldandi fjölpeptíð
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.3.2014EP published:
6.3.2019EP application number:
14769541.5
EP translation filed:
7.5.2019Grant published:
15.6.2019EPO information:
European Patent Register
Max expiry date:
13.3.2034Expiry date:
13.3.2027Next due date:
31.3.2027
Title:
AGLYCOSYLATED Fc-CONTAINING POLYPEPTIDES
Timeline
Today
14.3.2014EP application
6.3.2019EP Publication
7.5.2019Translation submitted
15.6.2019Registration published
13.3.2027Expires
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive, 91320-1799, Thousand Oaks, CA, US
Inventor
Name:
KANNAN, GunasekaranAddress:
Newbury ParkCalifornia, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361784669 PDate:
14.3.2013Country:
US
Classification
Categories:
C07K 14/55, A61K 38/20, C07K 16/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 24.4.2019
Expires: 13.3.2020
Payer: Árnason Faktor
Number: 7
Paid: 18.2.2020
Expires: 13.3.2021
Payer: Árnason Faktor ehf.
Number: 8
Paid: 8.2.2021
Expires: 13.3.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 17.2.2022
Expires: 13.3.2023
Payer: Patice ehf.
Number: 10
Paid: 22.2.2023
Expires: 13.3.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 5.3.2024
Expires: 13.3.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 4.3.2025
Expires: 13.3.2026
Payer: Árnason Faktor ehf.
Number: 13
Paid: 20.3.2026
Expires: 13.3.2027
Payer: Árnason Faktor ehf.